Cargando…
Decreasing Incidence of Gastric Cancer with Increasing Time after Helicobacter pylori Treatment: A Nationwide Population-Based Cohort Study
Background: Treatment of Helicobacter pylori (HP) has been shown to reduce the risk of gastric cancer (GC) development. However, previous studies have focused on patients at high risk of GC. This study aimed to assess the effect of HP treatment on the incidence of GC in the general population. Mater...
Autores principales: | Kim, Taewan, Seo, Seung In, Lee, Kyung Joo, Park, Chan Hyuk, Kim, Tae Jun, Kim, Jinseob, Shin, Woon Geon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405442/ https://www.ncbi.nlm.nih.gov/pubmed/36009921 http://dx.doi.org/10.3390/antibiotics11081052 |
Ejemplares similares
-
Aspirin, metformin, and statin use on the risk of gastric cancer: A nationwide population‐based cohort study in Korea with systematic review and meta‐analysis
por: Seo, Seung In, et al.
Publicado: (2021) -
Incidence and Survival Outcomes of Colorectal Cancer in Long-Term Metformin Users with Diabetes: A Population-Based Cohort Study Using a Common Data Model
por: Seo, Seung In, et al.
Publicado: (2022) -
Risk for Colorectal Neoplasia in Patients With Helicobacter pylori Infection: A Systematic Review and Meta-analysis
por: Choi, Da Sol, et al.
Publicado: (2020) -
Bismuth-Based Quadruple Therapy versus Metronidazole-Intensified Triple Therapy as a First-Line Treatment for Clarithromycin-Resistant Helicobacter pylori Infection: A Multicenter Randomized Controlled Trial
por: Seo, Seung In, et al.
Publicado: (2022) -
Statin Use Decreases the Risk of Metachronous Gastric Cancer in Patients without Helicobacter pylori Infection
por: Kwon, Tae Jin, et al.
Publicado: (2021)